134 related articles for article (PubMed ID: 11791192)
1. [The vigilance paradigm in schizophrenia research - studies on the Continuous Performance Test (CPT)].
Mass R
Fortschr Neurol Psychiatr; 2002 Jan; 70(1):34-9. PubMed ID: 11791192
[TBL] [Abstract][Full Text] [Related]
2. Re-examining sustained attention deficits as vulnerability indicators for schizophrenia: stability in the long term course.
Liu SK; Hsieh MH; Hwang TJ; Hwu HG; Liao SC; Lin SH; Chen WJ
J Psychiatr Res; 2006 Oct; 40(7):613-21. PubMed ID: 16904125
[TBL] [Abstract][Full Text] [Related]
3. [Vulnerability to schizophrenia. III: Importance and limits of the Identical Pairs Continuous Performance Test].
Laurent A; Rochet T; D'Amato T; Anchisi AM; Daumal M; Favre P; Bougerol T; Dalery J
Encephale; 2000; 26(2):48-55. PubMed ID: 10858916
[TBL] [Abstract][Full Text] [Related]
4. [Disorders of early information processing and vigilance as vulnerability markers for schizophrenia].
Suslow T; Arolt V
Fortschr Neurol Psychiatr; 1996 Mar; 64(3):90-104. PubMed ID: 8900889
[TBL] [Abstract][Full Text] [Related]
5. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia.
van Hoof JJ; Jogems-Kosterman BJ; Sabbe BG; Zitman FG; Hulstijn W
J Psychiatr Res; 1998; 32(2):99-103. PubMed ID: 9694005
[TBL] [Abstract][Full Text] [Related]
7. Bimodal response sensitivity and bias in a test of sustained attention contrasting patients with schizophrenia and bipolar disorder to normal comparison group.
Baerwald JP; Tryon WW; Sandford J
Arch Clin Neuropsychol; 2005 Jan; 20(1):17-32. PubMed ID: 15620812
[TBL] [Abstract][Full Text] [Related]
8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
9. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study.
Kurtz MM; Moberg PJ; Ragland JD; Gur RC; Gur RE
Schizophr Bull; 2005 Jan; 31(1):167-74. PubMed ID: 15888434
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
11. Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus Continuous Performance Test.
Mass R; Wolf K; Wagner M; Haasen C
Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):24-30. PubMed ID: 10738861
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
[TBL] [Abstract][Full Text] [Related]
13. Sustained attention deficits in nonpsychotic relatives of schizophrenic patients: a recurrence risk ratio analysis.
Chen WJ; Chang CH; Liu SK; Hwang TJ; Hwu HG;
Biol Psychiatry; 2004 May; 55(10):995-1000. PubMed ID: 15121483
[TBL] [Abstract][Full Text] [Related]
14. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
Sarolta K; Pál C; István B
Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
[TBL] [Abstract][Full Text] [Related]
15. Correlation between performance on the Continuous Performance Test and economic costs in patients with schizophrenia.
Ko SY; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yang MJ
Psychiatry Clin Neurosci; 2003 Aug; 57(4):373-7. PubMed ID: 12839517
[TBL] [Abstract][Full Text] [Related]
16. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).
Nuechterlein KH; Green MF; Calkins ME; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL
Schizophr Res; 2015 Apr; 163(1-3):38-46. PubMed ID: 25749017
[TBL] [Abstract][Full Text] [Related]
17. Dimensions of attention impairment and negative symptoms in schizophrenia: a multidimensional approach using the conners continuous performance test in a Spanish population.
Sanz JC; Gómez V; Vargas ML; Marín JJ
Cogn Behav Neurol; 2012 Jun; 25(2):63-71. PubMed ID: 22543264
[TBL] [Abstract][Full Text] [Related]
18. Cognitive performance and basic symptoms in first-degree relatives of schizophrenic patients.
Bove EA
Compr Psychiatry; 2008; 49(4):321-9. PubMed ID: 18555050
[TBL] [Abstract][Full Text] [Related]
19. Initial and final work performance in schizophrenia: cognitive and symptom predictors.
Bryson G; Bell MD
J Nerv Ment Dis; 2003 Feb; 191(2):87-92. PubMed ID: 12586961
[TBL] [Abstract][Full Text] [Related]
20. Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD.
Biederman J; Petty CR; Fried R; Doyle AE; Spencer T; Seidman LJ; Gross L; Poetzl K; Faraone SV
Acta Psychiatr Scand; 2007 Aug; 116(2):129-36. PubMed ID: 17650275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
